mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |